- Conditions
- Postmenopausal Osteoporosis
- Interventions
- Alendronate
- Drug
- Lead sponsor
- Radius Health, Inc.
- Industry
- Eligibility
- 50 Years to 85 Years · Female only
- Enrollment
- 1,139 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 3
- States / cities
- Lakewood, Colorado • Hialeah, Florida • Bethesda, Maryland
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 72
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Osteonecrosis
- Interventions
- Observational
- Other
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 30 Years to 90 Years
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2011
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Polyostotic Fibrous Dysplasia
- Interventions
- Fosamax (Alendronate)
- Drug
- Lead sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
- NIH
- Eligibility
- 6 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1998 – 2011
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Bone Density, Bone Loss, Anorexia Nervosa, Eating Disorder, Atypical Anorexia Nervosa
- Interventions
- Denosumab 60 MG [Prolia], Placebo Injection, Alendronate 70Mg Tab
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 20 Years to 60 Years · Female only
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- Ibandronate
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- Female only
- Enrollment
- 1,711 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 142
- States / cities
- Birmingham, Alabama • Columbiana, Alabama • Huntsville, Alabama + 128 more
- Conditions
- Asthma
- Interventions
- Alendronate, Placebo
- Drug
- Lead sponsor
- Milton S. Hershey Medical Center
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 78 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 10
- States / cities
- Tucson, Arizona • San Francisco, California • Denver, Colorado + 5 more
- Conditions
- Heart Transplantation, Liver Transplantation, Bone Resorption
- Interventions
- Zoledronic acid, Alendronate, Placebo Zoledronic Acid, Placebo Alendronate
- Drug · Other
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 20 Years to 70 Years
- Enrollment
- 111 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2014
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Osteoporosis, Cystic Fibrosis
- Interventions
- alendronate sodium, calcium carbonate, cholecalciferol
- Drug
- Lead sponsor
- University of North Carolina
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1998 – 2002
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina
- Conditions
- Renal Insufficiency
- Interventions
- Zoledronic Acid, Calcium with vitamin D, Alendronate
- Drug · Combination Product
- Lead sponsor
- University of Nebraska
- Other
- Eligibility
- 19 Years and older
- Enrollment
- 59 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2014
- U.S. locations
- 1
- States / cities
- Omaha, Nebraska
- Conditions
- Breast Carcinoma, Calcification
- Interventions
- Computed Tomography, Copper Cu-64-DOTA-alendronate, Pharmacokinetic Study, Positron Emission Tomography
- Procedure · Drug · Other
- Lead sponsor
- City of Hope Medical Center
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 1
- States / cities
- Duarte, California
- Conditions
- IOP, Osteoporosis
- Interventions
- Alendronate, Zoledronic Acid
- Drug
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 20 Years to 55 Years · Female only
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 2
- States / cities
- Omaha, Nebraska • New York, New York
- Conditions
- Osteopenia, Osteoporosis
- Interventions
- risedronate, alendronate
- Drug
- Lead sponsor
- Warner Chilcott
- Industry
- Eligibility
- 40 Years to 75 Years · Female only
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2004
- U.S. locations
- 2
- States / cities
- Gainesville, Florida • New Orleans, Louisiana
- Conditions
- Osteoporosis
- Interventions
- raloxifene HCI and alendronate Na
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 50 Years to 80 Years · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 73
- States / cities
- Anniston, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 70 more
- Conditions
- Hyperparathyroidism
- Interventions
- Alendronate 70mg weekly
- Drug
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Spinal Cord Injury, Bone Loss, Osteoporosis
- Interventions
- Alendronate, Calcium, Vitamin D
- Drug · Dietary Supplement
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Osteoporosis
- Interventions
- Alendronate
- Drug
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 5 Years to 14 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2008
- U.S. locations
- 1
- States / cities
- Charleston, South Carolina
- Conditions
- Osteoporosis
- Interventions
- Teriparatide, Alendronate Sodium, Placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 428 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2008
- U.S. locations
- 6
- States / cities
- Loma Linda, California • Palo Alto, California • Aurora, Colorado + 3 more
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- teriparatide, aldrenodate, raloxifene
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 50 Years and older · Female only
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2007
- U.S. locations
- 10
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Scottsdale, Arizona + 7 more
- Conditions
- Low Bone Density
- Interventions
- Teriparatide, Alendronate, calcium and vitamin D
- Drug · Dietary Supplement
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 50 Years to 80 Years · Female only
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2020
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Gaucher's Disease, Osteopenia
- Interventions
- alendronate sodium, calcium carbonate, cholecalciferol
- Drug
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Other
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 82 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1998 – 2002
- U.S. locations
- 2
- States / cities
- Cincinnati, Ohio • Dayton, Ohio
- Conditions
- HIV Infection
- Interventions
- Alendronate, Placebo, Calcium carbonate/vitamin D
- Drug · Dietary Supplement
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 11 Years to 24 Years
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2017
- U.S. locations
- 7
- States / cities
- Los Angeles, California • Miami, Florida • Tampa, Florida + 4 more
- Conditions
- Osteoporosis
- Interventions
- alendronate with cholecalciferol, calcium carbonate with cholecalciferol, Falls prevention measures
- Drug · Behavioral
- Lead sponsor
- Hebrew SeniorLife
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Perimenopausal Bone Loss
- Interventions
- Fosamax
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 40 Years to 54 Years · Female only
- Enrollment
- 48 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2002 – 2007
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Osteoporosis, Osteopenia
- Interventions
- Alendronate, Calcium Citrate, Vitamin D
- Drug · Dietary Supplement
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 59 Years and older · Female only
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2009
- U.S. locations
- 1
- States / cities
- Chicago, Illinois